Correlagen is a leading developer of genetic testing that helps physicians to diagnose disease earlier and more precisely for more tailored treatment. Founded by researchers from Harvard and Children’s Hospital Boston, Correlagen provides high-quality testing through the use of automated systems and sophisticated result interpretation and reporting. Correlagen’s customers range from private practitioners to researchers at some of the world’s foremost academic institutions.
|
Genes That Matter™
|
|
About 1 in 500 Americans have hypertrophic cardiomyopathy, a genetic disease that is the most common cause of sudden cardiac death in young adults and athletes. Genetic testing can aid in diagnosis of HCM and help to identify affected family members, ensuring that at-risk individuals receive appropriate monitoring and medical care. Learn more...
|
|
Please note change of address for Correlagen’s laboratory testing site!
Please send all samples expected to arrive on or after Monday, November 10, 2008, to
Correlagen Diagnostics, Inc
307 Waverley Oaks Road, Suite 101
Waltham, MA 02452
(781) 647-0604
|
|
GINA has been signed into law!
-
Click here
to learn more about GINA, the Genetic Information Nondiscrimination Act
Please Note:
Turn-around times for test results are typically 14 days for family tests,
21 days for single-gene tests, and 4-6 weeks for multi-gene panels.
Preliminary reports based on partial sequence results will be released when
a pathogenic variant is found or when the report is more than 10 days
overdue due to technical difficulties with a small part of the sequence.
|
